l -5-Hydroxytryptophan treatment of sleep terrors in children
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Unlabelled To test the hypothesis that the administration of L -5-hydroxytryptophan (L -5-HTP) might exert beneficial effects on sleep terrors, we carried out an open pharmacological trial in a group of children with sleep terrors compared to a group of children with the same disorder but without L -5-HTP treatment. Participants in the trial were 45 children (34 males and 11 females; age range 3.2-10.6 years), referred to the Sleep Centre of the Department of Developmental Neurology and Psychiatry of the University of Rome "La Sapienza", affected by sleep terrors. All subjects underwent: (1) complete medical and sleep history; (2) complete neurological examination and EEG recording whilst awake and sleeping, (3) a structured sleep diary for 2 months, (4) after 1 month, all subjects were examined again from the clinical and EEG points of view and (5) after 6 months, a structured interview in order to evaluate the clinical outcome. After the first visit, L -5-HTP was administered (2 mg/kg per day) at bedtime to 31 randomly selected patients for a single period of 20 consecutive days. After 1 month of treatment, 29/31 (93.5%) of patients showed a positive response. In the comparison group without drug therapy, after 1 month, the episodes disappeared only in four children (28.6%) while ten children (71.4%) showed the persistence of episodes with the same frequency as before. After 6 months, 26/31 (83.9%) of children treated with L -5HTP were sleep terror-free, while in five children (16.1%) sleep terror episodes persisted. Of the children in the comparison group, ten (71.4%) continued to show sleep terrors at 6-month follow-up.Conclusion to our knowledge, this is the first study demonstrating the efficacy of a new drug treatment for sleep terrors. These results confirm our initial hypothesis and represent evidence that treatment with L -5-hydroxytryptophan is able to modulate the arousal level in children and to induce a long-term improvement of sleep terrors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melatonin (N-acetyl-5-methoxytryptamine) has also been found to be useful [17, 76, 80-82].”
From Sleep Terrors: An Updated Review (2020) · cites this paper as [80]
In the citing paper
“In children with ST, L-OH-tryptophan (a precursor of serotonin) at high doses (2 mg/Kg) is probably the medication of choice [118]”
From Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults (2023) · cites this paper as [118]
In the citing paper
“This study reported 94% efficacy (meaning >50% reduction in the number of reported episodes) at the 1-month follow-up and 84% efficacy at the 6-month follow-up, after a single period of treatment over 20 consecutive days.”
From Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults (2023) · cites this paper as [118]
Citations
Cites
The International Classification of Sleep Disorders: Diagnostic and Coding Manual
Daroff, R. B. (1991) · Neurology · doi:10.1212/wnl.41.1.160 · Cited by 5,014
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576 · cited 1×
“It has been suggested that the manifestations of arousal disorders, such as sleep terrors, may be due to a conflict between the mechanisms generating slow-wave sleep and arousal, dependent on a dysfunction in the serotoninergic system [1,16].”
BackgroundSleepwalking and Sleep Terrors in Prepubertal Children: What Triggers Them?
Guilleminault, C., Palombini, L., Pelayo, R., & Chervin, R. D. (2003) · Pediatrics · doi:10.1542/peds.111.1.e17 · Cited by 369
Espa, F., Ondze, B., Deglise, P., Billiard, M., & Besset, A. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00249-2 · Cited by 202 · cited 1×
“It has been demonstrated that the number and the duration of high voltage monomorphic delta (HVMD) activity or of hypersynchronous high voltage delta waves arousal (HSDWA) during sleep is increased in adults and children with sleep terrors [4, 10,11] and that an increase in sleep instability and in arousal oscillation…”
BackgroundZucconi, M., Oldani, A., Ferini‐Strambi, L., & Smirne, S. (1995) · PubMed · Cited by 155
Zucconi, M., Oldani, A., Ferini-Strambi, L., & Smirne, S. (1995) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199503000-00005 · Cited by 153 · cited 2×
“It has been demonstrated that the number and the duration of high voltage monomorphic delta (HVMD) activity or of hypersynchronous high voltage delta waves arousal (HSDWA) during sleep is increased in adults and children with sleep terrors [4, 10,11] and that an increase in sleep instability and in arousal oscillation…”
BackgroundEFFECTS OF L-TRYPTOPHAN (A NATURAL SEDATIVE) ON HUMAN SLEEP
Wyatt, R. J., Engelman, K., Kupfer, D. J., Fram, D. H., Sjoerdsma, A., & Snyder, F. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92015-5 · Cited by 137 · cited 3×
“At therapeutic doses, this substance does not affect the normal distribution of sleep stages in both acute and chronic treatment [29,34].”
BackgroundEvaluation of l-tryptophan for treatment of insomnia: A review
Schneider-Helmert, D., & Spinweber, C. L. (1986) · Psychopharmacology · doi:10.1007/bf00175180 · Cited by 105 · cited 3×
“At therapeutic doses, this substance does not affect the normal distribution of sleep stages in both acute and chronic treatment [29,34].”
BackgroundResultNovel and non-toxic treatment for night terrors.
Lask, B. (1988) · BMJ · doi:10.1136/bmj.297.6648.592 · Cited by 82
Ryan, N. D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110007001 · Cited by 81 · cited 1×
“side-effects [8, 17, 26, 28].”
Serotonergic functioning in depressed abused children: clinical and familial correlates
Kaufman, J., Birmaher, B., Perel, J., Dahl, R. E., Stull, S., Brent, D., Trubnick, L., Al-Shabbout, M., & Ryan, N. D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00203-0 · Cited by 69 · cited 1×
“side-effects [8, 17, 26, 28].”
Sleep Terror Disorder and Insomnia Treated with Trazodone: A Case Report
Balon, R. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409148998 · Cited by 64 · cited 1×
“parents [32]; an approach based on psychotherapy or hypnosis [10,19]; waking treatment [20]; and a pharmacological approach using different classes of medication such as benzodiazepines and tricyclic antidepressants [3, 5, 6, 23, 25].”
Gijsman, H. J., van Gerven, J. M. A., de Kam, M. L., Schoemaker, R. C., Pieters, M. S. M., Weemaes, M., de Rijk, R., van der Post, J., & Cohen, A. F. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00012 · Cited by 55 · cited 1×
“After the neurological evaluation and the recording of the EEG, a dosage of 2 mg/kg per day of L -5-HTP [13, 24, 30] was administered at bedtime to all patients of group A for a single period of 20 consecutive days.”
Method5-hydroxytryptophan, but not l-tryptophan, alters sleep and brain temperature in rats
Imeri, L., Mancia, M., Bianchi, S., & Opp, M. R. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00435-2 · Cited by 50 · cited 1×
“doses of L -5-hydroxytryptophan ( L -5-HTP), a precursor of serotonin, might cause the production of sleeppromoting factors [15].”
BackgroundThe Pharmacologic Treatment of Sleep Disorders
Dahl, R. E. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30263-6 · Cited by 48 · cited 1×
“parents [32]; an approach based on psychotherapy or hypnosis [10,19]; waking treatment [20]; and a pharmacological approach using different classes of medication such as benzodiazepines and tricyclic antidepressants [3, 5, 6, 23, 25].”
Stockenhuber, D. (2001) · Deutsche Zeitschrift für Akupunktur · doi:10.1055/s-2001-14481 · Cited by 48
The Natural History of Night Terrors
DiMario, F. J., & Emery, E. S. (1987) · Clinical Pediatrics · doi:10.1177/000992288702601002 · Cited by 47
Tryptophan Contaminants Associated with Eosinophilia-Myalgia Syndrome
Philen, R. M., Hill, R. H., Flanders, W. D., Caudill, S. P., Needham, L. L., Sewell, L., Sampson, E. J., Falk, H., & Kilbourne, E. M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116841 · Cited by 46
An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan.
Michelson, D., Sw, P., Casey, R., Trucksess, M., La, L., Milstien, S., Wilson, C., Massaquoi, S. G., Crofford, L. J., & Hallett, M. (1994) · PubMed · Cited by 46
Sleep-Terror Disorder in Children: The Role of Self-Hypnosis in Management
Kohen, D. P., Mahowald, M. W., & Rosen, G. M. (1992) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.1992.10402853 · Cited by 44 · cited 1×
“parents [32]; an approach based on psychotherapy or hypnosis [10,19]; waking treatment [20]; and a pharmacological approach using different classes of medication such as benzodiazepines and tricyclic antidepressants [3, 5, 6, 23, 25].”
Efficacy and safety of midazolam in the treatment of night terrors in children.
Popoviciu, L., & Corfariu, O. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02278.x · Cited by 34 · cited 1×
“parents [32]; an approach based on psychotherapy or hypnosis [10,19]; waking treatment [20]; and a pharmacological approach using different classes of medication such as benzodiazepines and tricyclic antidepressants [3, 5, 6, 23, 25].”
The Serotoninergic System and Sleep-Wakefulness Regulation
Adrien, J. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_5 · Cited by 33 · cited 1×
“It has been suggested that the manifestations of arousal disorders, such as sleep terrors, may be due to a conflict between the mechanisms generating slow-wave sleep and arousal, dependent on a dysfunction in the serotoninergic system [1,16].”
BackgroundEvaluation of flurazepam and placebo on sleep disorders in childhood
Reimão, R., & Lefèvre, A. B. (1982) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1982000100001 · Cited by 29 · cited 1×
“parents [32]; an approach based on psychotherapy or hypnosis [10,19]; waking treatment [20]; and a pharmacological approach using different classes of medication such as benzodiazepines and tricyclic antidepressants [3, 5, 6, 23, 25].”
Giorgis, G. D., Miletto, R., Iannuccelli, M., Camuffo, M., & Scerni, S. (1987) · PubMed · Cited by 27
ABC of sleep disorders. Parasomnias.
Driver, H. S., & Shapiro, C. M. (1993) · BMJ · doi:10.1136/bmj.306.6882.921 · Cited by 25
Schruers, K. R. J., van Diest, R., Nicolson, N. A., & Griez, E. J. L. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1072-8 · Cited by 24 · cited 1×
“After the neurological evaluation and the recording of the EEG, a dosage of 2 mg/kg per day of L -5-HTP [13, 24, 30] was administered at bedtime to all patients of group A for a single period of 20 consecutive days.”
MethodRibeiro, C., & For The Portuguese Headache Society (2000) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00067.x · Cited by 24 · cited 1×
“side-effects [8, 17, 26, 28].”
A Novel Neurodevelopmental Syndrome Responsive to 5-Hydroxytryptophan and Carbidopa
Ramaekers, V. T., Senderek, J., Häusler, M., Häring, M., Abeling, N. G. G. M., Zerres, K., Bergmann, C., Heimann, G., & Blau, N. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3187 · Cited by 23 · cited 1×
“After the neurological evaluation and the recording of the EEG, a dosage of 2 mg/kg per day of L -5-HTP [13, 24, 30] was administered at bedtime to all patients of group A for a single period of 20 consecutive days.”
MethodLithium carbonate and the "cycloid spectrum".
Cameron, O. G., & Thyer, B. A. (1985) · PubMed · Cited by 22
Klarskov, K., Johnson, K. L., Benson, L. M., Cragun, J. D., Gleich, G. J., Wrona, M. Z., Jiang, X.-R., Dryhurst, G., & Naylor, S. (2003) · PubMed · Cited by 21
Daniels, S. R., Hudson, J. I., & Horwitz, R. I. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00503-x · Cited by 19 · cited 1×
“L -trytophan and EMS and contest the validity of the conclusions from these studies [7,31], although the debate about the cause-effect relationship is still open.”
BackgroundProblems with over-the-counter 5-hydroxy-L-tryptophan
Williamson, B. L., Klarskov, K., Tomlinson, A. J., Gleich, G. J., & Naylor, S. (1998) · Nature Medicine · doi:10.1038/1951 · Cited by 17 · cited 1×
“with L -5-HTP in the literature [18, 21,33] and, again,”
BackgroundShapiro, S. (1996) · PubMed · Cited by 13
Is Drug Treatment of Night Terrors Warranted?
WEISSBLUTH, M. (1984) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1984.02140490086028 · Cited by 8
Riemann, D. W., & Vorderholzer, U. (1998) · PubMed · Cited by 8
[Eosinophilia-myalgia syndrome associated with 5-OH-tryptophan. Description of a case].
Farinelli, S., Mariani, A., Grimaldi, A., Mariani, M. B., Iannessi, A., & ROSA, F. D. (1991) · PubMed · Cited by 6
Cited by
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
“A randomized controlled study of 3weeks’ treatment with 5-hydroxytryptamine in children found evidence of efficacy at 6-month follow-up (Bruni et al., 2004).”
MethodHow important is tryptophan in human health?
Kałużna-Czaplińska, J., Gątarek, P., Chirumbolo, S., Chartrand, M. S., & Bjørklund, G. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1357534 · Cited by 333
“These results confirm that arousal level might be positively influenced by treatment with L-5-hydroxytryptophan, resulting in reduced sleep terror behaviors in children (Bruni et al., 2004).”
BackgroundWilson, S., Anderson, K., Baldwin, D., Dijk, D.-J., Espie, A., Espie, C., Gringras, P., Krystal, A., Nutt, D., Selsick, H., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855343 · Cited by 312
“A randomised controlled study of three weeks’ treatment with 5-hydroxytryptophan in children found evidence of efficacy at six-month follow-up (Bruni et al., 2004).”
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010181 · Cited by 236
“In a group of children with sleep terrors, treatment with 5-HTP was able to modulate the arousal level and to induce a long-term improvement of sleep terrors [156].”
Sleep disorders during childhood: a practical review
Ophoff, D., Slaats, M., Boudewyns, A. N., Glazemakers, I., Hoorenbeeck, K. V., & Verhulst, S. L. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3116-z · Cited by 173
Metadata
- Authors
- Bruni, O., Ferri, R., Miano, S., & Verrillo, E.
- Affiliations
- Sapienza University of Rome (IT)
- Oasi Maria SS (IT)
- Corresponding author
- Bruni, Oliviero
- Venue
- European Journal of Pediatrics
- Published
- 2004-05-14
- Volume
- 163
- Issue
- 7
- Pages
- 402-7
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- OpenAlex
- W1996708083
- Cited by
- 108
- References
- 35
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 11 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 8 · 2015: 1 · 2014: 4 · 2013: 6 · 2012: 2
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- sleep terrors, L-5-hydroxytryptophan, children, pharmacotherapy, serotonin precursor, sleep disorders, arousal level, treatment efficacy
- MeSH terms
- Child, Child, Preschool, Female, Follow-Up Studies, Humans, 5-Hydroxytryptophan, Male, Treatment Outcome, Night Terrors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.